大規模元宇宙商標申請正面臨國家知識產權局“勸退”
格隆匯1月24日丨據科創板日報,近期,包括小紅書元宇宙、愛奇藝奇遇元宇宙、探探元宇宙等商標申請被駁回複審。國家知識產權局人士對此迴應記者表示,元宇宙是一項新技術,不能作爲商標被個人獨佔,否則容易產生誤認。天眼查數據顯示,2021年6月至今,總共有1510個主體(178個自然人,1332家公司)申請了元宇宙商標,數量總共9965個商標。在中國商標網查詢發現,目前暫無公司成功註冊“元宇宙”相關商標。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.